03/05/2026
How PGx Results Become Metabolizer Status 🚥
Pharmacogenomic testing begins by identifying genetic variants within genes that influence drug metabolism.
But identifying variants is only the first step.
Those variants must then be interpreted using established functional data to determine how they affect enzyme activity. In some genes, this process includes evaluating allele function, variant combinations, and in certain cases activity scoring methods.
The result of this interpretation is a predicted metabolizer status such as poor, intermediate, normal, or ultrarapid metabolizer.
These phenotype categories help translate complex genetic data into information that can guide medication decisions.
At Advanced Genetics Laboratory (AGL) and PGx Analysis, genetic findings are carefully interpreted using validated reference data and pharmacist reviewed analysis to ensure that results are clinically meaningful.
Because raw genetic data alone does not guide prescribing. Interpretation does.
Learn more at 🌐 www.advancedgeneticslab.com